http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
미세변화 신증후군에 합병된 간문맥, 비장정맥 및 장간막정맥 혈전증
조종태(Jong Tae Cho),김지훈(Ji Hoon Kim),박정식(Jung Sik Park),이상구(Sang Koo Lee),김순배(Soon Bae Kim),양현숙(Hyun Suk Yang),조경식(Kyoung Sik Cho) 대한신장학회 2000 Kidney Research and Clinical Practice Vol.19 No.3
An association between nephrotic syndrome and thromboembolic phenomena has been known for many years. Most common sites of venous throm-bosis in nephrotic syndrome are al vein and deep vein of lower extremity. We report a case of minimal change nephrotic syndrome associated with unusual extensive venous thrombosis. A 29-year-old man was transferred to our hospital with severe abdominal pain and ascites. 2 months before admission, he was diagnosed as minimal change nephropathy at another hospital and treated with steroid therapy but he had persistent proteinuria on admission. The ab- dominal ultrasonography and CT scan revealed diffuse thrombosis of left renal vein, splenic vein, su-perior mesenteric vein and portal vein. Deep vein thrombosis of lower extremity was also found but not pulmonary embolism. There was no evidence of other primary hypercoagulable disease. He was treat- ed with intravenous heparin immediately and three days later, abdominal pain disappeared. Prednisolone and cyclophosphamide were administered as well. After 1 month of therapy, proteinuria was resolved. Abdominal CT scan, taken after 2 months of therapy, revealed that diffuse thrombosis were almost re- solved. From this case, diffuse abdominal thrombosis should be included as a diffrential diagnosis in a ne-phrotic patient with abdominal pain.
조종태(Jong Tae Cho),이재균(Jae Gyoon Lee),윤성철(Sung Chul Yun),박현민(Hyun Min Park) 대한내과학회 1999 대한내과학회지 Vol.56 No.1
Objectives : Hearing loss, mainly a sensorineural hearing loss (SNHL), was frequently observed in patient with chronic renal failure. Although several causes and prevalence of this hearing loss had been proposed, the etiology and prevalence are still controversial. The purpose of the present study was another study to determine the prevalence, type and comparative degree of hearing loss in chronic renal failure according to various parameters. Methods : Subjects for this study were 39 patients with hemodialysis and 10 chronic renal failure patients before hemodialysis. Pure tone audiometry was performed and pure tone average(PTA) was estimated. At same time, pure tone threshold were estimated at the range from 250 to 500(low frequency range), from 1000 to 2000(middle frequency range) and from 4000 to 8000 Hz(high frequency range). Significant hearing loss of PTA as well as the significant loss in pure tone threshold of each frequency range was defined when the loss of hearing ability was 25dB more than the normal value. The effect of alteration in age, sex, hemoglobin, lipid profile, duration of hemodialysis, underlying diseases and ototoxic drugs were evaluated. Result : 1) The main type of hearing loss was SNHL and it was asymptomatic and progressive. The prevalence of SNHL by means of PTA was 76% in the patient with chronic renal failure. The SNHL of high frequency range(89%), SNHL of middle frequency range(18%) and SNHL of low frequency range (45%) were observed on the basis of the pure tone threshold. 2) There was no significant difference of SNHL according to various parameters of sex, hemoglobin, lipid profile, BUN, and underlying diseases except age. 3) The patients under hemodialysis exhibited the more SNHL over all frequency ranges than those without hemodialysis and there was the more SNHL in patients of more than 2 years of hemodialysis and those of less than 2 years of hemodialysis 4) Furosemide was significantly ototoxic in patients with chronic renal failure.Conclusion : The type of hearing loss was mainly sensori-neural and high tone loss. The degree was slight to moderate. The prevalence was the higher than expected. Regular hemodialysis treatment seems to affect hearing loss during even 2 years of treatment. Therefore, hearing loss appeared to be related to the duration of hemodialysis. The more precise and regular audiometric monitorings were recommanded in hemodilalysis patients.
항사구체기저막 항체 및 MPO-ANCA 양성인 초승달 사구체신염
조종태 ( Jong Tae Cho ),고재향 ( Jai Hyang Go ),정경연 ( Kyong Yeun Jung ) 대한내과학회 2012 대한내과학회지 Vol.83 No.5
Rapidly progressive glomerulonephritis (RPGN) is a clinical syndrome involving abrupt or insidious onset of hematuria, proteinuria, and anemia, and rapidly progressive renal failure. Crescentic glomerulonephritis is a histopathological term for RPGN showing extensive extracapillary proliferation, i.e., crescent formation. There are three major immunopathological categories of crescentic glomerulonephritis: anti-glomerular basement membrane (anti-GBM) antibody disease, immune complex-mediated, and pauci-immune (anti-neutrophil cytoplasmic autoantibody [ANCA]-positive). A small minority of all patients with glomerulonephritis develop crescentic glomerulonephritis. Anti-GBM antibodies and ANCA rarely coexist. There have been a few reports of dual positive crescentic glomerulonephritis with anti-GBM antibodies and ANCA in Korea. Here, we describe the case of a 73-year-old woman showing RPGN clinically and crescentic glomerulonephritis pathologically with coexisting anti-GBM antibodies and myeloperoxidase-ANCA. (Korean J Med 2012;83:654-658)
막증식성 사구체 신염을 동반한 면역글로불린 G4 연관 신장 질환 1예
조종태 ( Jong Tae Cho ),이은경 ( Eun-kyoung Lee ),고재향 ( Jai Hyang Go ),이용문 ( Yong-moon Lee ),이화영 ( Hwa Young Lee ),김소미 ( So Mi Kim ) 대한내과학회 2021 대한내과학회지 Vol.96 No.1
Immunoglobulin G4 (IgG4)-related kidney disease is a chronic immune-mediated fibro-inflammatory disorder characterized by multiple organ infiltration with IgG4-positive plasma cells, storiform fibrosis, and obliterative phlebitis or tumefactive lesions. Previous studies have explored IgG4-related kidney disease, increasing our understanding of its clinical manifestations, and pathological and radiologic findings. However, IgG4-related kidney disease can be misdiagnosed since it mimics malignancies. We report a case of a 77-year-old Korean man diagnosed with IgG4-related kidney disease with membranous proliferative glomerulonephritis, presenting with a renal pelvic mass suspected of being malignant. (Korean J Med 2021;96:48-52)
조종태(Jong Tae Cho),김근호(Geun Ho Kim),엄재호(Jae Ho Earm),안규리(Gu Rie Ahn),한진석(Jin Suk Han),김성권(Suhng Gwon Kim),이정상(Jung Sang Lee) 대한내과학회 1990 대한내과학회지 Vol.39 No.6
N/A We observed the clinical features, underlying disorders, complications, treatment and outcome of 12 cases of distal renal tubular acidosis and the following results were obtained. 1) The patient`s age ranged from 23 to 53 years old (39±9) and female to male ratio was 10:2. 2) The chief complaints on admission were generalized weakness (5), periodic paralysis (4), recurrent renal stone (2) and paresthesia (1). 3) The identified underlying disorders were systemic lupus erythematosus (3), medullary spongy kidney (2), Sjogren`s syndrome (2), and hyperparathyroidism (1). 4) The major complications were nephrolithiasis (3), nephrocalcinosis (3), osteomalacia (2) and rhabdomyolysis (1). 5) Replacement of alkali and potassium, and specific therapy for underlying disorders showed good outcome.
트리테이스프로텍트 <sup>®</sup>정(라미프릴 10mg)에 대한 라미프린 <sup>®</sup>정의 생물학적동등성
오수연,조종태,김형건,김윤균,Oh, Soo-Yeon,Cho, Jong-Tae,Kim, Hyung-Gun,Kim, Yoon-Gyoon 한국약제학회 2008 Journal of Pharmaceutical Investigation Vol.38 No.1
To evaluate the bioequivalence of two ramipril formulations, a standard 2-way randomized cross-over study was conducted in twenty-six healthy male Korean volunteers. A single oral dose of 10 mg of test formulation $Ramiprin^{(R)}$ (tablet) or reference formulation Tritace $Protect^{(R)}$ (tablet) was administered with one-week washout period. Plasma concentrations of ramipril were assayed over a period of 12 hr with a well validated method using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The values of area under the plasma concentration-time curve, from time zero to last sampling time $(AUC_t)$ and from time zero to time infinity $(AUC_{inf})$ were $77.45{\pm}44.78\;and\;78.96{\pm}45.64$ for test, and $70.30{\pm}42.27\;and\;71.99{\pm}43.55ng\;hr/mL$ for reference formulation, respectively. Similarly, maximum concentration $(C_{max})$ and elimination half-life $(t_{1/2})$ were $65.61{\pm}19.96ng/mL$ and $2.15{\pm}0.75hr$ for test, and $63.63{\pm}25.50ng/mL$ and $2.16{\pm}0.73hr$ for reference formulations, respectively. Time to reach maximum concentration $(T_{max})$ for the test and the reference, were $0.51{\pm}0.22hr\;and\;0.52{\pm}0.18hr$, respectively. The parametric 90% confidence intervals on the mean of the differences between the two formulations (test-reference) of the log-transformed values of $AUC_t\;and\;C_{max}$ were 1.03 to 1.19 and 0.98 to 1.17, respectively. The overall results indicate that the two formulations are bioequivalent and can be prescribed interchangeably.
김근호(Gheun Ho Kim),조종태(Jong Tae Cho),양원석(Won Suk Yang),김윤구(Yoon Goo Kim),한진석(Jin Suk Han),김성권(Suhng Gwon Kim),이정상(Jung Sang Lee) 대한내과학회 1991 대한내과학회지 Vol.40 No.1
In order to observe the sequential changes of the urine electrolytes and urine anion gap (UAG) during the course of Korean hemorrhagic fever (KHF), we measured spot urine electrolytes and urine osmolality in 16 patients with KHF, and calculated UAG from them as an index of the renal tubular dysfunction. Also, we observed the relationships between the initial value of spot urine anion gap and the clinical findings and severity in each patient. Spot urine sodium and potassium concentrations were higher in the early phases (oliguric to early diuretic phase) than in the late phases. Spot UAG values were highest in the oliguric phase and decreased sequentially. Urine osmolality decreased sequentially from the oliguric to the convalescent phase. The initial spot UAC values of each patient were related with the clinical severity in the early phases and with the degrees of hyponatremia, azotemia and metabolic acidosis as well. Spot UAG was elevated when spot urine sodium or potassium concentration was higher, and was lowered when urine osmolality was decreased or polyuria occurred. From the above results, we concluded that the changes of spot UAG through the phases might be related with the renal tubular damage in KHF.